Inventor
KEVIN R. CONDROSKI
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07DHeterocyclic compounds30%
C07BGeneral methods of organic chemistry10%
PatentTitleYear
12,338,235Heterocyclic compounds and their use for treatment of helminthic infections and diseases202511,970,485RET kinase inhibitors202411,964,968Compounds useful for inhibiting RET kinase202411,697,647RET kinase inhibitors202311,613,533Compounds useful for inhibiting RET kinase202311,505,548Heterocyclic compounds and their use for treatment of helminthic infections and diseases2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to CELGENE CORP (2)· patent assignee history
2022–2025Patents assigned to ZOETIS LLC (2)· patent assignee history
2022–2025Based in US· patent location history
2023–2024Patents assigned to LILLY CO ELI (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| LILLY CO ELI | 4 | 2023–2024 |
| CELGENE CORP | 2 | 2022–2025 |
| ZOETIS LLC | 2 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2022–2025 |